End Stage Renal Disease Clinical Trials in San Francisco, California
2 recruitingSan Francisco, California
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Arteriovenous FistulaEnd Stage Renal DiseaseKidney Disease, End-Stage
C. R. Bard280 enrolled17 locationsNCT04634916
Recruiting
Phase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
End Stage Renal DiseasePrimary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 enrolled18 locationsNCT04580420